OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164954. A total of 3 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $13,000 | 0.0% | 31,000 | +38.4% | 0.00% | – |
| Q1 2016 | $13,000 | -72.3% | 22,400 | -17.9% | 0.00% | – |
| Q4 2015 | $47,000 | -65.7% | 27,300 | -57.9% | 0.00% | – |
| Q3 2015 | $137,000 | -29.0% | 64,800 | +66.6% | 0.00% | – |
| Q2 2015 | $193,000 | -73.3% | 38,900 | -57.9% | 0.00% | -100.0% |
| Q1 2015 | $723,000 | +343.6% | 92,400 | +243.5% | 0.00% | – |
| Q4 2014 | $163,000 | -67.9% | 26,900 | -77.4% | 0.00% | -100.0% |
| Q3 2014 | $508,000 | +15.2% | 119,200 | +67.2% | 0.00% | 0.0% |
| Q2 2014 | $441,000 | +22.2% | 71,300 | +28.2% | 0.00% | – |
| Q1 2014 | $361,000 | -31.2% | 55,600 | -40.3% | 0.00% | -100.0% |
| Q4 2013 | $525,000 | -1.3% | 93,200 | +7.6% | 0.00% | 0.0% |
| Q3 2013 | $532,000 | +88.0% | 86,600 | +78.9% | 0.00% | – |
| Q2 2013 | $283,000 | – | 48,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 437,400 | $2,165,000 | 0.03% |
| SIMPLEX TRADING, LLC | 30 | $6,000 | 0.00% |
| Citadel Advisors | 38,900 | $193,000 | 0.00% |